IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition

Detalles Bibliográficos
Autores principales: Alicke, Bruno, Varfolomeev, Eugene, Lee, Shi Hui Kaylee, Frommlet, Alexandra, Ubhayakar, Savita, Quinn, John G., Fairbrother, Wayne J., Jones, Robert, Gould, Stephen E., Vucic, Domagoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519744/
https://www.ncbi.nlm.nih.gov/pubmed/36171193
http://dx.doi.org/10.1038/s41419-022-05283-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519744/
https://www.ncbi.nlm.nih.gov/pubmed/36171193
http://dx.doi.org/10.1038/s41419-022-05283-w

Ejemplares similares